Triosephosphate Isomerase Level in Relation to Rheumatoid Aerthritis Activity and Structural Damage

Sponsor
Assiut University
Study ID
NCT07105566
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - 50 Years
Healthy Volunteers
Not accepted

Interventions

  • serum TPI — DIAGNOSTIC_TEST
    serum TPI level

Study Details

1. Assess the serum level of TPI in patients with RA compared to healthy controls. 2. Correlate serum level of TPI and disease activity. 3. Correlation of serum TPI level with US7 damage index

Key Dates

First listed
Aug 6, 2025
Start date
Sep 30, 2025
Status verified
Aug 2025
Primary completion
Sep 30, 2027
Completion
Oct 31, 2027

Study Design

Enrollment
70 participants (estimated)

Arms

  • Arm: cases
    Rheumatoid Arthritis pateints
  • Arm: controls
    healthy controls

Primary Outcome Measure

Serum Triosephosphate Isomerase (TPI) concentration (ng/mL) in Rheumatoid Arthritis (RA) patients [ Time Frame: baseline ]

Central Contacts

Find similar trials

Nationwide
Rheumatoid arthritis trialsRheumatology trialsAutoimmune disease trialsMusculoskeletal disorders trials

Related Studies